Position in XGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,426,168
+$1,344,301 QoQ
Shares Held
306,703
+1023.9% QoQ
Ownership
1.27%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 57 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $832,085,876 across 26 Diagnostics & Research names. XGN ranks #19 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WAT |
Waters Corp /De/
|
581,332 | $218,022,752 | |
| 2 | QGEN |
Qiagen N.V.
|
3,491,480 | $136,516,866 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
76,977 | $98,338,886 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
342,995 | $77,787,835 | |
| 5 | DGX |
Quest Diagnostics Inc
|
269,760 | $57,175,631 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
93,128 | $49,026,303 | |
| 7 | NTRA |
Natera, Inc.
|
131,663 | $35,739,920 | |
| 8 | ICLR |
Icon PLC
|
175,440 | $30,475,681 |
All Filings in XGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,426,168 | 306,703 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $81,867 | 27,289 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,480,017 | 243,424 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $270,705 | 24,632 | Shares | Other | 2025-11-13 | |
| 2025-03-31 | $382,546 | 106,559 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $65,796 | 16,048 | Shares | Other | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||